COPD & Emphysema Support Group
COPD is a progressive disease characterized by airflow obstruction or limitation. Emphysema is characterized by loss of elasticity of the lung tissue, destruction of structures supporting the alveoli and of capillaries feeding the alveoli. Both have symptoms that include shortness of breath, among other respiratory troubles. If you are a COPD or Emphysema sufferer, join...
Dylan Bushell-Embling (Australian Life Scientist)
16 December, 2011 16:39
Hunter Immunology is currently developing a vaccine to treat chronic obstructive pulmonary diseases (COPD) including chronic bronchitis and emphysema.
The company is in the final stages of phase IIb clinical trials involving 320 patients across 21 Australian hospitals. Results from the trial are scheduled to be released in April 2012.
The preceding phase IIa trial showed a reduction in hospital admissions for COPD patients by 90%.
You can read the whole story here if you like.
http://www.lifescientist.com.au/article/410513/hunter_immunology_agrees_probiomics_merger/
I thought some of us might be interested in this.
Love
Holly
16 December, 2011 16:39
Hunter Immunology is currently developing a vaccine to treat chronic obstructive pulmonary diseases (COPD) including chronic bronchitis and emphysema.
The company is in the final stages of phase IIb clinical trials involving 320 patients across 21 Australian hospitals. Results from the trial are scheduled to be released in April 2012.
The preceding phase IIa trial showed a reduction in hospital admissions for COPD patients by 90%.
You can read the whole story here if you like.
http://www.lifescientist.com.au/article/410513/hunter_immunology_agrees_probiomics_merger/
I thought some of us might be interested in this.
Love
Holly
( Though using the term Vaccine is curious...)
http://www.youtube.com/watch?v=Mb-u2NW-bxY
All the clinical trials are good and I love reading about them, some will fail and some will bring good thing our way.
Its good to know they are working to help us.
Love,
Holly
It sounds like it could be promising, but I'm not sure a trial with only 320 patients will be enough to reach market in 5 years. But hopefully they will do more extensive studies to achieve that aim.
Is it the next stage on from this one do you think?
http://copd.about.com/b/2010/05/01/oral-vaccine-may-help-people-with-copd.htm
I'm not sure if I like the sound of the vaccine combination.
Hopefully future trialling / studies will prove safe and promise.